Skip to content

TLX 5902931P2Recalls & reported problems

Nuvasive, Inc. · TLX20, 9x11x31mm 20° · Class 2 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00887517958419), received between Jan 14, 2025 and Mar 14, 2025 — classified as 2 injuries, 1 malfunction.

The most frequently reported specific device problem is “Migration” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 2 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Migration1

Patient problems

  • Ambulation or Postural Difficulties1
  • Back pain1
  • Chest Pain1
  • Limb Pain1
  • Muscle Weakness/Atrophy1
  • No Clinical Signs, Symptoms or Conditions1
  • Numbness1
  • Pneumonia1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 14, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE EVENT WAS IDENTIFIED DURING A REVIEW OF THE LUMBAR INTERBODY STUDY, THE REPORT IDENTIFIED THAT ON (B)(6) 2024 TRANSFORAMINAL LUMBAR INTERBODY FUSION AT L5-S1 WITH BILATERAL POSTERIOR FIXATION L5-S1. ON (B)(6) 2024 PULMONARY EMBOLISM PRESENTED TO THE ED ON (B)(6)2024 WITH ACUTE ONSET CHEST PAIN THAT RADIATES INTO THE BACK PAIN WAS SO SEVERE PATIENT TOOK AN OXYCODONE PRIOR TO ED ARRIVAL. ON EXAM IN ED, AFEBRILE, TACHYPNEA, SATING 93% RA AND CT SHOWED SMALL ACUTE PE AND RIGHT UPPER LOBE, RIGHT LOWER LOBE SHOWS GROUND-GLASS CHANGES WITH ATELECTASIS CONCERN FOR POSSIBLE PULMONARY INFARCT. PATIENT WAS ADMITTED ON HEPARIN DRIP. ALSO CONCERN FOR COMMUNITY ACQUIRED PNEUMONIA BASED ON CT AND ELEVATED WBC. STABLE ON DISCHARGE ON (B)(6) 2024 ON (B)(6) 2025, PATIENT HAS BEEN EXPERIENCING SIGNIFICANTLY WORSENING LLE PAIN, WORSE SINCE SURGERY. REPORTS A LIMP AND DIFFICULTY AMBULATING WITH HIS LLE, REPORTING THIS IS NEW SINCE SURGERY. ALSO DOES REPORT EPISODES OF HIS LEFT LEG GIVING OUT ON HIM AND LLE WEAKNESS. PATIENT REPORTS SIGNIFICANT PAIN BEHIND LEFT KNEE AND OUTSIDE LEFT KNEE AND LEG TURNING INTO NUMBNESS ON THE OUTER PORTION OF HIS FOOT AND TOES. HE REPORTS HIS TOES ARE CURLED.

    Patient problems: Ambulation or Postural Difficulties; Limb Pain; Muscle Weakness/Atrophy; Numbness

    MAUDE report 21609912 ↗
  • InjuryMar 11, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE EVENT WAS IDENTIFIED DURING A REVIEW OF THE LUMBAR INTERBODY STUDY, THE REPORT IDENTIFIED THAT ON (B)(6) 2024 TRANSFORAMINAL LUMBAR INTERBODY FUSION AT L5-S1 WITH BILATERAL POSTERIOR FIXATION L5-S1. ON (B)(6) 2024 PULMONARY EMBOLISM PRESENTED TO THE ED ON (B)(6) 2024 WITH ACUTE ONSET CHEST PAIN THAT RADIATES INTO THE BACK PAIN WAS SO SEVERE PATIENT TOOK AN OXYCODONE PRIOR TO ED ARRIVAL. ON EXAM IN ED, AFEBRILE, TACHYPNEA, SATING 93% RA AND CT SHOWED SMALL ACUTE PE AND RIGHT UPPER LOBE, RIGHT LOWER LOBE SHOWS GROUND-GLASS CHANGES WITH ATELECTASIS CONCERN FOR POSSIBLE PULMONARY INFARCT. PATIENT WAS ADMITTED ON HEPARIN DRIP. ALSO CONCERN FOR COMMUNITY ACQUIRED PNEUMONIA BASED ON CT AND ELEVATED WBC. STABLE ON DISCHARGE ON (B)(6) 2024

    Patient problems: Back pain; Chest Pain; Pneumonia; Pulmonary Embolism; Tachycardia

    MAUDE report 21578331 ↗
  • MalfunctionJan 14, 2025Migration; Migration

    THE EVENT WAS IDENTIFIED DURING A REVIEW OF THE PMCF LUMBAR INTERBODY STUDY, THE REPORT IDENTIFIED THAT ON (B)(6) 2022 A PATIENT UNDERWENT A TWO LEVEL TRANSFORAMINAL LUMBAR INTERBODY FUSION PROCEDURE AT L4/5 AND L5/S1. ON (B)(6) 2022 FOLLOW UP RADIOGRAPHS NOTED SUBSIDENCE OF BOTH INTERBODY'S (L4-5, L5-S1). NO REVISION OR TREATMENT PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21149470 ↗

Other Intervertebral fusion device with bone graft, lumbar devices

All Intervertebral fusion device with bone graft, lumbar devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page